Wilkins Miller Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$463K Buy
3,604
+22
+0.6% +$2.58K 0.25% 66
2026
Q1
$431K Buy
3,582
+25
+0.7% +$2.89K 0.26% 65
2025
Q4
$374K Sell
3,557
-142
-4% -$13.3K 0.22% 66
2025
Q3
$311K Buy
3,699
+8
+0.2% +$659 0.19% 74
2025
Q2
$292K Buy
3,691
+34
+0.9% +$2.7K 0.2% 72
2025
Q1
$328K Sell
3,657
-110
-3% -$10.3K 0.25% 67
2024
Q4
$375K Buy
+3,767
New +$388K 0.39% 47

Other funds holding MRK

Wilkins Miller Wealth Management's MRK Position: Q2 2026 in Review

Wilkins Miller Wealth Management increased its Merck (MRK) stake by 0.61% in Q2 2026, buying an estimated $2.58K and bringing the position to 3,604 shares worth $463K. The position accounts for 0.25% of the portfolio, ranked #66.

Wilkins Miller Wealth Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,153 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Wilkins Miller Wealth Management held 3,604 shares of Merck worth $463K as of Q2 2026.
  • Wilkins Miller Wealth Management bought 22 Merck shares in Q2 2026, an estimated $2.58K.
  • Merck made up 0.25% of Wilkins Miller Wealth Management's portfolio in Q2 2026, its #66 holding.
  • Wilkins Miller Wealth Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,153 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Wilkins Miller Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.